To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02448589
Title An Investigation of TAS-119 Monotherapy and in Combination With Docetaxel
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | ESP

Facility Status City State Zip Country Details
University Hospitals - Seidman Cancer Center Cleveland Ohio 44106 United States Details
San Raffaele Hospital Milano 20132 Italy Details
Erasmus MC Cancer Institute Rotterdam 3015CE Netherlands Details
START MADRID-FJD, Hospital Fundación Jiménez Díaz Madrid 28040 Spain Details
START Madrid Unidad de Ensayos Fase I Madrid 28050 Spain Details
The Institute of Cancer Research Sutton Surrey SM2 5NG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field